Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen
about
Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccineTRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus MonkeysProtection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccinesImmunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challengeRole of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesProtection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsInfluence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS modelPassive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.Non-human primate models for AIDS vaccine research.Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccineAssembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in MacaquesViral sequence diversity: challenges for AIDS vaccine designs.Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus
P2860
Q28387636-EACF60BF-B263-45AB-8FA6-C97270C0DA62Q28472608-CDE13671-B0E9-49A8-9BF9-EF8AC6E726C4Q33644522-16C0880C-DAE8-4DF2-97EC-5BC88AB21698Q33799497-2168D502-B377-45CB-A75C-7E580C009129Q33819493-EC046966-5EB3-48D4-8B0F-0FFDC3B23BF2Q33852720-98DD2967-EFC9-415B-8E89-DFBFB9987CE6Q33912052-181F9696-9BDE-43B2-B101-5E1427DF40E7Q34150125-316DE988-74EC-4367-AD56-65B28535CDD2Q34715769-93954655-D788-4E61-8049-E64F94C6483CQ35123128-3ED6BA1C-9E2C-4A63-AF2C-41F58C0FEBAEQ36177537-C9F3D611-83F4-48C1-96EA-DF43319348E6Q36248882-9EF9AE22-F193-4D16-AB7C-5698936030D6Q36628390-C36F48C5-A8F1-43F2-AA4B-70749D873D64Q36665647-ABC003C0-63D9-4A0A-A54A-B80EE5FE5A91Q37316023-69E3A7FD-4D0C-4A39-A895-BAB1395CD3EBQ37374425-6597F2E0-21D1-446D-8AC1-B9CFF92FBAF6Q37830048-910B5E9B-C173-4ADC-A13A-816FD80B7002Q39593235-9C007426-C1DD-40F2-A7EF-33B178E7384A
P2860
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Limited breadth of the protect ...... mbination immunization regimen
@ast
Limited breadth of the protect ...... mbination immunization regimen
@en
type
label
Limited breadth of the protect ...... mbination immunization regimen
@ast
Limited breadth of the protect ...... mbination immunization regimen
@en
prefLabel
Limited breadth of the protect ...... mbination immunization regimen
@ast
Limited breadth of the protect ...... mbination immunization regimen
@en
P2093
P2860
P1433
P1476
Limited breadth of the protect ...... mbination immunization regimen
@en
P2093
A J Langlois
B A Richardson
D C Montefiori
J E Klaniecki
J Overbaugh
P Polacino
R E Benveniste
V Stallard
W R Morton
P2860
P304
P577
1999-01-01T00:00:00Z